These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10160551)

  • 41. Harvard Pilgrim Health Care--leading the competition and growing.
    Scott K
    Health Syst Lead; 1997 May; 4(5):13-22. PubMed ID: 10167539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does higher HMO penetration reduce commercial premiums?
    Capitation Rates Data; 2001 Jun; 6(6):67-70. PubMed ID: 11436729
    [No Abstract]   [Full Text] [Related]  

  • 43. It is time to move from health maintenance to health promotion.
    Goldman RL; Adamson TE; Raymond GL; Schore JE
    J Hosp Mark; 1989; 3(2):115-9. PubMed ID: 10295616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Providers watch Medicare experiment with competition.
    Yanish DL
    Mod Healthc; 1981 Aug; 11(8):62-3, 70. PubMed ID: 10298227
    [No Abstract]   [Full Text] [Related]  

  • 45. Perspectives. Hybrids take center stage as new phase in cost war looms.
    Cunningham R
    Faulkner Grays Med Health; 1997 Apr; 51(14):suppl 1-4. PubMed ID: 10165838
    [No Abstract]   [Full Text] [Related]  

  • 46. Medicare risk contracting: identifying factors associated with market exit.
    Porell FW; Tompkins CP
    Inquiry; 1993; 30(2):157-69. PubMed ID: 8314604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What determines hospital sponsorship of an HMO?
    McCue MJ
    Inquiry; 2000; 37(3):268-81. PubMed ID: 11111284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profits under pressure. The economic performance of investor-owned and nonprofit health maintenance organizations.
    Schlesinger M; Blumenthal D; Schlesinger E
    Med Care; 1986 Jul; 24(7):615-27. PubMed ID: 3088342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new measure of the impact of managed care on healthcare markets.
    Pawlson LG; Moy EM; Kim JI; Griner PF
    Am J Manag Care; 2001 Nov; 7(11):1069-77. PubMed ID: 11725810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Managed competition in health care and the unfinished agenda.
    Enthoven AC
    Health Care Financ Rev; 1986; 1986(Spec No):105-19. PubMed ID: 10311922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hospital market structure, hospital competition, and consumer welfare: what can the evidence tell us?
    Pautler PA; Vita MG
    J Contemp Health Law Policy; 1994; 10():117-67. PubMed ID: 10134808
    [No Abstract]   [Full Text] [Related]  

  • 52. Hospital participation in competitive markets for ambulatory care: implications for reimbursement policy.
    Friedman B; Manheim L; Melczer A
    Adv Health Econ Health Serv Res; 1983; 4():83-127. PubMed ID: 10265659
    [No Abstract]   [Full Text] [Related]  

  • 53. Health care costs--past, present, and future.
    Meyerhoff J
    Md Med J; 1985 Feb; 34(2):167-74. PubMed ID: 3837140
    [No Abstract]   [Full Text] [Related]  

  • 54. Competition and health cost containment: cautions and conjectures.
    Brown LD
    Milbank Mem Fund Q Health Soc; 1981; 59(2):145-89. PubMed ID: 6908948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The determinants of HMO enrollment and growth.
    Goldberg LG; Greenberg W
    Health Serv Res; 1981; 16(4):421-38. PubMed ID: 7327943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of HMO ownership on hospital costs and revenues: is there a difference between for-profit and nonprofit plans?
    Shen YC; Melnick G
    Inquiry; 2004; 41(3):255-67. PubMed ID: 15669744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attempts of control health care costs: the United States experience.
    Newman JF; Elliott WB; Gibbs JO; Gift HC
    Soc Sci Med (1967); 1979 Aug; 13A(5):529-40. PubMed ID: 472782
    [No Abstract]   [Full Text] [Related]  

  • 58. Market analysis documents HMO premium increases by region.
    Capitation Manag Rep; 2002 Feb; 9(2):24-6. PubMed ID: 11892408
    [No Abstract]   [Full Text] [Related]  

  • 59. Getting to the core of marketplace issues.
    Prescott M
    HMO; 1995; 36(6):91-2, 95, 97. PubMed ID: 10153452
    [No Abstract]   [Full Text] [Related]  

  • 60. Must good HMOs go bad? First of two parts: the commercialization of prepaid group health care.
    Kuttner R
    N Engl J Med; 1998 May; 338(21):1558-63. PubMed ID: 9599120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.